ICON：2025年AI赋能临床研发：AI在药物开发中的实战应用白皮书（英文版）

As a disruptive technology, Artificial Intelligence (AI) is currently the subject of a great deal of excitement and hype – so much so that it can be difficult to objectively assess its capabilities and promise. It is clear, though, that AI has the potential to transform business processes across the spectrum of clinical development – from clinical trial design, through to recruitment and clinical operations, all the way to commercialisation and outcomes. AI can deliver reasonably unbiased and